Table 1. Clinical and biochemical tests assessed or collected immediately before each intervention and at 7 AM on the second intervention day during both interventions (n = 10).
9 AM before start of intervention (first intervention day) |
7 AM (second intervention day) |
||||
---|---|---|---|---|---|
Median (IQR) | p-Value | Median (IQR) | p-Value | ||
S-cortisol (nmol/L) | HC | 43.2 (38.0–55.1) | 0.36 | 298 (228–359) | <0.001 |
Saline | 46.7 (43.1–61.7) | 44.4 (36.8–52.5) | |||
Overnight U-free cortisol (µg/7 hr)*,† | HC | – | 678 (459–814) | <0.001 | |
Saline | – | <0.01‡ | |||
S-cortisone (nmol/L) | HC | 40.7 (29.5–49.2) | 0.76 | 81.2 (60.5–94.9) | <0.001 |
Saline | 42.1 (29.7–50.4) | 42.0 (28.9–47.3) | |||
Overnight U-free cortisone (µg/7 hr)*,† | HC | – | 136 (106–151) | <0.001 | |
Saline | – | <0.01‡ | |||
SBP (mmHg) | HC | 122 (111–134) | 0.88 | 123 (107–139) | 0.65 |
Saline | 127 (112–131) | 124 (101–137) | |||
DBP (mmHg) | HC | 76 (63–83) | 0.88 | 69 (59–76) | 0.55 |
Saline | 72 (67–80) | 65 (60–70) | |||
S-sodium (mmol/L) | HC | 141 (139–142) | 0.85 | 140 (138–141) | 0.97 |
Saline | 141 (138–142) | 140 (138–141) | |||
S-potassium (mmol/L) | HC | 4.4 (4.3–4.7) | 0.27 | 4.4 (4.3–4.8) | 0.26 |
Saline | 4.2 (4.0–4.5) | 4.4 (4.3–4.5) | |||
P-glucose (mmol/L) | HC | 5.0 (4.5–5.3) | 0.79 | 5.6 (5.2–5.8) | 0.08 |
Saline | 5.0 (4.6–5.1) | 5.2 (5.2–5.4) | |||
Body weight (kg) | HC | 72.2 (69.6–77.3) | 0.53 | 72.8 (69.3–77.7) | 0.63 |
Saline | 73.5 (70.5–79.5) | 74.0 (70.5–79.2) |
*Overnight U-free cortisol and cortisone were collected from midnight to morning (12 AM to 7 AM) during physiological GC exposure (HC infusion) and GC withdrawal (saline infusion).
†One of the 10 subjects was not included in the analysis because of a problem during sample collection.
‡Below the limit of detection.
DBP: diastolic blood pressure; GC: glucocorticoid; HC: hydrocortisone; IQR: interquartile range; P: plasma; S: serum; SBP: systolic blood pressure; U: urinary.